E. Salomoni

Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort

E. Ricci, A. De Vito, P. Bonfanti, 2020, Infection and drug resistance.

Evaluation of the prognostic value of liver stiffness in patients with hepatitis C virus treated with triple or dual antiviral therapy: A prospective pilot study.

S. Milani, F. Marra, B. Boldrini, 2015, World journal of gastroenterology.

Candida glabrata prosthetic hip infection.

A. Bartoloni, P. Pecile, F. Bartalesi, 2012, American journal of orthopedics.

Non‐invasive assessment of liver fibrosis in patients with HBV‐related chronic liver disease undergoing antiviral treatment: A preliminary study

S. Milani, F. Marra, M. Pinzani, 2017, European journal of pharmacology.

Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role?

S. Babudieri, E. Ricci, K. Falasca, 2016, European journal of gastroenterology & hepatology.

Risk factors for non-invasive/invasive ventilatory support in patients with COVID-19 pneumonia: A retrospective study within a multidisciplinary approach

P. Blanc, R. Papa, Tommaso Meconi, 2020, International Journal of Infectious Diseases.

Very short course of triple therapy including telaprevir for chronic hepatitis C: a possible strategy in selected patients.

G. Corti, E. Salomoni, F. Baragli, 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19)

D. Francisci, F. Vichi, P. Pierotti, 2021, Journal of Infection.

Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study

E. Grifoni, F. Piani, R. Tarquini, 2020, Infectious Diseases.

The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile

E. Ricci, K. Falasca, P. Bonfanti, 2020, Drug design, development and therapy.

Optimal branching of human arterial bifurcations.

E Fanucci, A. Orlacchio, E. Fanucci, 1990, Investigative radiology.

Chronic hepatitis C virus hepatitis and psoriasis: No longer a contraindication to interferon use in the era of biological agents?

N. Pimpinelli, A. Bartoloni, F. Bartalesi, 2013, Scandinavian Journal of Infectious Diseases.

Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients – evidence from a large observational cohort

F. Incardona, M. Zazzi, A. De Luca, 2019, Infectious diseases.